Description

Reta Overview
Reta, commonly known as Retatrutide, is a synthetic investigational peptide designed as a multi-receptor agonist targeting GLP-1, GIP, and glucagon signaling pathways. It is currently examined in laboratory and clinical research for its potential involvement in metabolic regulation, glucose balance, and body weight dynamics. Through activation of multiple incretin and glucagon receptors, Retatrutide demonstrates broad biological activity that continues to be investigated within metabolic and endocrine research models.

History
The development of Reta, or Retatrutide, is based on decades of scientific research into incretin-related metabolic pathways. Early investigations of GLP-1 receptor agonists highlighted their role in regulating glucose metabolism and appetite signaling. Later advancements introduced dual agonists such as tirzepatide, which targets both GLP-1 and GIP receptors. Building on this research foundation, Retatrutide was developed to engage GLP-1, GIP, and glucagon receptors simultaneously, representing a newer direction in peptide science focused on comprehensive metabolic pathway investigation in laboratory and clinical research environments.

Retatrutide Structure

CAS #: 2381089-83-2

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈

Molecular Weight: 4845.44 g/mol

PubChem ID: 474492335

Research Findings
Reta, also referred to as Retatrutide, has been investigated in metabolic and systemic research models, with studies examining its interaction with glucose regulation, insulin signaling pathways, lipid metabolism, and integrated hormone activity. Research also highlights its involvement in energy balance and multi-system signaling in preclinical and controlled laboratory environments.

Key Areas of Research:

• Metabolic: Glucose regulation, insulin signaling, energy balance
• Endocrine: GLP-1 activity, GIP pathways, glucagon signaling
• Cardiovascular: Lipid metabolism, cholesterol regulation, hepatic pathways
• Systemic: Multi-hormone signaling, biological stability, metabolic balance

Together, these observations indicate broad experimental relevance for Retatrutide across metabolic, cardiovascular, and systemic research models. By interacting with multiple hormone signaling pathways, it provides a useful framework for studying energy regulation, lipid metabolism, and integrated biological signaling across complex physiological systems.